Constantine Logothetis, MD
Hometown: Albuquerque, NM |
Medical School: University of New Mexico, School of Medicine |
Residency: University of South Florida, Morsani College of Medicine |
Research/Academic Interests: Academic interest: Malignant hematology. Research interests: Early phase clinical and translational research in myeloid malignancies. |
Bio: I was born and raised in Albuquerque, New Mexico. I love to travel, experience different cultures, and learn new languages. I enjoy watching hockey, bike riding, and reading. I am fascinated with aviation, and I am aspiring to obtain my private pilot’s license. |
Selected Publications/Abstracts
- Alderuccio JP, Arcaini L, Watkins M, Beaven AW, Shouse G, Epperla N, Stefanovic A, Sandoval-Sus J, Torka P, Alpert AB, Olszewski AJ, Kim SH, Hess B, Gaballa S, Ayyappan S, Castillo JJ, Argnani L, Voorhees TJ, Saba R, Chowdhury SM, Vargas F, Reis IM, Kwon D, Jonathan A, Zhao W, Edwards D, Martin P, Kamdar M, Brian Link B, Logothetis CN, Herrera AF, Friedberg JW, Kahl BS, Luminari S, Zinzani PL, Lossos IS
An International Analysis Testing Frontline Bendamustine with Rituximab in Extranodal Marginal Zone Lymphoma
Blood Adv. 2022 Apr 12;6 (7): 2035-2044 Cited in PubMed PMID: 35196377 - Horvat NP, Logothetis CN, Zhang L, Yun S, Sweet K. Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia
Cureus. 2022 Mar 29;14(3):e23618. PMID: 35505715 - Gajzer D, Logothetis CN, Sallman DA, Calon G, Babu A, Chan O, Vincelette ND, Volpe VO, Al Ali NH, Basra P, Talati C, Kuykendall AT, Mo Q, Padron E, Sweet K, Komrokji RS, Lancet JE, Yun S†, Zhang L†.
MYC overexpression is associated with an early disease progression from MDS to AML
*DG and CNL contributed equally as co-first authors; †SY and ZL contributed equally as co-corresponding authors
Leuk Research, 2021 Oct 21;111:106733. Cited in PubMed PMID: 34749168 - Logothetis CN, Jordan A, Weppelmann T, Zhang S, Hanna C, Charkowick S, Oxner A. The Clinical Utility of Serum D-dimer Levels to Evaluate Hospitalized Novel Coronavirus 2019 (COVID-19) Patients with Clinical Suspicion of Pulmonary Embolism
JAMA Netw Open. 2021 Oct 1;4(10):e2128802. Cited in PubMed PMID: 34623411 - Logothetis CN, Patel A, Eatrides J, Jaglal M, Haider M, Visweshwar N, Laber DA. Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution
J Clin Med. 2021 Jul 31;10(15):3418. Cited in PubMed PMID: 34362201 - Mirza AS, Kumar A, Hashmi H, Garcia F, Logothetis CN, Darwin A, Bachmeier CA, Chavez JC, Shah BD, Pinilla-Ibarz J, Khimani F, Lazaryan A, Liu H, Davila ML, Nishihori T, Locke FL, Jain MD. Incidence and Management of Effusions during CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Receptor Therapy in B-Cell Lymphoma: A Single Institution Experience
Transplant Cell Ther. 2021 Mar.27(3): 242.e1-242.e6. EPub 2020 Dec 27. Cited in PubMed PMID: 33781520 - Logothetis CN, Fernandez J, Laber DA. Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight
Case Rep Med. 2021 Dec 7:2021:2551964. eCollection 2021. Cited in PubMed PMID: 34917152 - Logothetis CN, Konstantinov NK, Reyes MD, Emil NS, Tzamaloukas AH. Development of Lupus Erythematosus Tumidus During the Course of Systemic Sclerosis
Cureus 2021 Sep 17;13(9):e18064. Cited in PubMed PMID: 34671535 - Hashmi H, Mirza AS, Darwin A, Logothetis CN, Garcia F, Kommalapati A, Bachmeier CA, Chavez JC, Shah BD, Pinilla-Ibarz J, Khimani F, Lazaryan A, Liu H, Davila ML, Jain M.D, Locke FL, Nishihori T.
Venous Thrombo-Embolism Associated with CD19-Directed CAR T-Cell Therapy in Large B-Cell Lymphoma
Blood Adv. 2020 Sep 8;4(17):4086-4090. Cited in PubMed PMID: 32877523 - Logothetis CN, Pizanis C. Cerebral Venous Thrombosis in the Setting of Malignancy: Case Report and Review of the Literature
Case Rep Hematol. 2020 Sep.17;2020:8849252. eCollection 2020. Cited in PubMed PMID: 33014481 - Amoah SK, Rodriguez BA, Logothetis CN, Chander P, Sellgren C.M, Weick JP, Sheridan SD, Jantzie LL, Webster MJ, Mellios N. Exosomal Secretion of a Psychosis-altered miRNA that Regulates Glutamate Receptor Expression is Affected by Antipsychotics
Neuropsychopharmacology. 2020 Mar;45(4):656-665. Epub 2019 Nov 27. Cited in PMID: 31775160 - Shain KH, Renatino-Canevarolo R, Meads MB., Sudalagunta PR., Coelho MD, Silva S, Cubitt. C, De Avila G, Alugubelli RR, Kulkarni A, Zhang Q, Hampton O, Logothetis CN, Argueta C, Landesman Y, Silva AS.
Characterization of Synergistic Selinexor Combinations of Dexamethasone, Pomalidomide, Elotuzumab and Daratumumab in Primary MM Samples Ex Vivo
Blood (2020) 136 (Supplement 1): 29–30 - Logothetis CN, Talati C, Calon G, Horvat NP, Volpe VO, Vincelette N, Kuykendall AT, Chan O, Sallman DA, Padron E, Sweet K, Komrokji RS, Zhang L, Lancet JE, Yun S. Survival Outcomes and Adverse Events of IDH1/2 Mutant AML Patients Treated with IDH1/2 Inhibitors: A Single Institutional Experience. HemaSphere (2021), 5(S2), 669-670.
- Logothetis CN, Talati C, Calon G, Horvat NP, Volpe VO, Vincelette ND, Kuykendall AT, Chan O, Sallman DA, Padron E, Sweet KL, Komrokji RS, Zhang L, Lancet JE, Yun S. Outcomes of IDH1/2 Mutant AML Patients Treated with IDH1/2 Inhibitors: A Single Institutional Experience. J Clin Oncol, (2021), 39(S15), e19010.